Lftd Partners Inc (LIFD)
| Sector • Healthcare Industry • Major Pharmaceutical Preparations |
| Industry • Major Pharmaceutical Preparations |
| Sector • Healthcare |
Marvelous Top-line improvement by Lftd Partners Inc over the third quarter of 2022
Lftd Partners Inc announced third quarter of 2022 operating income of $0.49527 million
Published 2023-03-22T06:55:55+00:00
Goran Soko / CSIMarket.com Contributer
![pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/Dryvax_pd.jpg "pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Lftd Partners Inc announced earnings per share of $0.03 and Revenue of $16.78 million in the third quarter of 2022 financial report, company's earnings per share dived $0.03 per share, versus $0.14 eps, earned in the corresponding interval a preceding year, although Lftd Partners Inc saw its Revenue rise by 27.393 % in the corresponding period. From the Income per Share dropped by -85 % from $0.20 per share and Revenue Tumbled by -33.018 % from $16.78 million.
Bottom-line of $0.423 million in the financial span ending September 30 2022 fell by -81.06 % from $2.236 million in the corresponding period a year before. Lftd Partners Inc shifted it's focus on improving sales in the financial span ending September 30 2022, as a result net margin eased to 3.77%.
Operating earnings, fell -78.63% to $0.49527 million, squeezing Lftd Partners Inc 's operating margin to 4.41%, from 26.28% in the third quarter of 2021.
Lftd Partners Inc is expected to report next financial recent numbers on August 10, 2023.